Stock OMGA OMEGA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Omega Therapeutics, Inc.

Equities

OMGA

US68217N1054

Market Closed - Nasdaq
Other stock markets
 01:00:00 2024-07-03 pm EDT 		5-day change 1st Jan Change
1.89 USD -8.70% Intraday chart for Omega Therapeutics, Inc. -19.57% -37.21%
Jul. 01 Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 3000 Growth Index CI
Jul. 01 Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell Small Cap Comp Growth Index CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 3000 Growth Index
CI
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell Small Cap Comp Growth Index
CI
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 2000 Dynamic Index
CI
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 3000E Growth Index
CI
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell Small Cap Completeness Index
CI
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 3000E Index
CI
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 2500 Growth Index
CI
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
GL
Omega Therapeutics, Inc. Appoints Richard N. Kender to Board of Directors
CI
Raymond James Initiates Omega Therapeutics at Outperform Rating With $12 Price Target
MT
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer
AQ
Transcript : Omega Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 10:40 AM
Omega Therapeutics, Inc. Announces Termination of Yan Moore as Chief Medical Officer
CI
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
GL
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
GL
Omega Therapeutics, Inc. Appoints Kaan Certel, Ph.D., as Chief Business Officer
CI
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
GL
Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
GL
Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OMGA Stock
  4. News Omega Therapeutics, Inc.